Shellback Capital’s Stericycle Inc SRCL Stock Holding History

Shellback Capital’s Portfolio SRCL Stock Details SRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100,000	Closed	-$7.7M	–	98
2016 Q4	$7.7M	Buy	+100,000	New	+$7.55M	0.79%	49

Other funds holding SRCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Shellback Capital's SRCL Position: Q1 2017 in Review

Shellback Capital sold out of Stericycle Inc (SRCL) in Q1 2017, closing a stake of 100,000 shares — an estimated $7.7M sold.

Shellback Capital first reported a position in SRCL in Q4 2016 and held it in 1 quarter. The position peaked at $7.7M in Q4 2016. 566 funds tracked by Wall St. Rank hold SRCL as of Q1 2017.

Shellback Capital reported no remaining Stericycle Inc position as of Q1 2017 after selling out during the quarter.
Shellback Capital sold 100,000 Stericycle Inc shares in Q1 2017, an estimated $7.7M.
Shellback Capital first reported a position in Stericycle Inc in Q4 2016 and held it in 1 quarter.
Shellback Capital's Stericycle Inc position peaked at $7.7M in Q4 2016.
566 funds tracked by Wall St. Rank held Stericycle Inc as of Q1 2017.

Based on Shellback Capital's 13F filing for Q1 2017, filed 15 May 2017.